NewAmsterdam Pharma Company N.V.
NAMS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $39,527 | $0 | -$39,527 | -$92,177 |
| Dep. & Amort. | $64 | $45 | $52 | $51 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15,010 | $15,179 | $15,213 | $9,415 |
| Change in WC | -$10,351 | -$23,843 | $10,351 | -$7,980 |
| Other Non-Cash | -$77,019 | -$29,052 | -$22,557 | $53,210 |
| Operating Cash Flow | -$32,769 | -$37,671 | -$36,468 | -$37,481 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | -$88 | -$16 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$31,852 | -$183,711 | -$9,629 | $0 |
| Inv. Sales/Matur. | $34,400 | $24,663 | $12,500 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$62,176 |
| Investing Cash Flow | $2,506 | -$159,136 | $2,855 | -$62,179 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,892 | $3,425 | $0 | $455,026 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $6,519 | $1,585 |
| Financing Cash Flow | $5,892 | $3,425 | $6,519 | $456,611 |
| Forex Effect | $222 | $8,826 | $3,771 | -$7,937 |
| Net Chg. in Cash | -$24,149 | -$184,556 | -$23,323 | $349,014 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $563,864 | $748,420 | $771,743 | $422,729 |
| End Cash | $539,715 | $563,864 | $748,420 | $771,743 |
| Free Cash Flow | -$32,811 | -$37,759 | -$36,484 | -$37,484 |